# CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Article · Jiehui Deng, Eric S. Wang, Russell William Jenkins, Shuai Li, Ruben Dries, Kathleen B. Yates, Sandeep Chhabra, Wei Huang, Hongye Liu, Amir Reza Aref, Elena V. Ivanova, Cloud Peter Paweletz, Michaela Bowden, Chensheng Willa Zhou, Grit Sophie Herter-Sprie, Jessica A. Sorrentino, John Bisi, Patrick Hall Lizotte, Ashley A. Merlino, Max M. Quinn, Lauren E. Bufe, Annan Yang, Yanxi Zhang, Hua Zhang, Peng Gao and 22 more

- Archive id: doi:10.1158/2159-8290.cd-17-0915
- Published: 2017-11-03
- Venue: Cancer Discovery
- DOI: https://doi.org/10.1158/2159-8290.cd-17-0915
- PMID: 29101163
- Citations: 770
- Source URL: https://doi.org/10.1158/2159-8290.cd-17-0915
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.